Press release
Appetite (Eating) Disorders Market size in terms of volume and value -2024
Although it is not a new disease, an appetite disorder can be related to modern lifestyle. In an attempt to reduce the weight and bring the body into shape people tend to decrease the normal food consumption. It is largely explained as a disturbed eating habit or disorders leading to significant impairing of physical and psychological health of the patient. Eating disorder also occurs with variety of other psychiatric illnesses such as substance abuse, anxiety disorder, depression and other similar conditions. In addition, people suffering from appetite disorders can experience a wide range of physical health complications such as serious heart conditions and kidney failure among others which may lead to even death.Request Sample Copy of the Report@
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14945
Appetite disorder market: Categories
Two of the prominent categories of the eating disorders include anorexia nervosa and bulimia nervosa. In anorexia nervosa, people tend to starve themselves for extreme weight loss whereas in bulimia nervosa a person tend to vomit after having food more than a stipulated amount every time. Females are more prone to eating or appetite disorders as compared to men. According to an article published in Psychology Today, approximately 0.5% to 3.7% of the female population suffers from anorexia nervosa whereas, an estimated 1.1% to 4.2% of the female population have bulimia nervosa in their lifetime. In the United States approximately 7 million women and 1 million men suffer from appetite disorder
Appetite disorder market: Major drivers
Major drivers to appetite disorder include genetics, abnormal level of biochemical in the body, psychological and environmental factors. With respect to genetics, identical twins are more likely to have higher rate of eating disorder as compared to fraternal twins or other siblings. Stress is another prominent cause of eating disorders. Many research studies have found that patients suffering from bulimia and anorexia have considerably higher level of stress hormones such as cortisol and serotonin. Environmental factors such as family and relationship problems, sexual abuse, disturbed childhood and peer problem can also significantly contribute towards appetite disorders. Despite of all these findings till date, the exact cause of the eating disorders is still unknown.
Appetite disorder market: Available drugs
Available treatment for appetite disorder includes nutritional therapy and drug therapy. Some of the commonly used drugs include antidepressants, antipsychotics, calcium plus vitamin D supplement and gastrointestinal stimulants among others. Lack of awareness about the disorder and absence of professional help in developing economic countries are some of the key restraints to the uptake of appetite disorder market. Cultural, professional and social compulsions such as requirements in the entertainment industry, modeling and a blurred perception of what a healthy body should look like has been a major cause of anorexia and bulimia. Several not-for-profit organizations have been creating awareness of the problems caused by social perceptions and demands in society for having a thin body particularly in females. This was conventionally upheld as a parameter for visual appeal, but is now slowly changing, with reducing number of cases over the world.
Appetite disorder market: Affected regions
Geographically, developed economic countries such as the United States and Europe are more prone to appetite disorder as compared to developing economic region primarily due to unhealthy eating habits and lifestyle related disorders. Intense research and development and awareness among people regarding eating disorder in developed economic countries are another contributing factor for increase in revenues in these two geographic regions. Many companies such as GlaxoSmithKline plc, Medisyn Technologies, Inc., Omeros Corporation are conducting rigorous clinical trial activities to develop novel drugs for patient suffering from appetite disorders. Asia-Pacific and Rest of the World are one of the fastest growing region owing to increase in disposable income, increasing influence and impact of camouflaging western culture lifestyle and rising incidences of obesity related disorders among mid-aged people.
Some of the prominent companies operating in Appetite (Eating) Disorders Market include GlaxoSmithKline plc, INSYS Therapeutics, Inc., Global Health Ventures Inc., Omeros Corporation, Kuhnil Pharmaceutical Co., Ltd., Medisyn Technologies, Inc., Lightlake Therapeutics Inc. among other players.
Request TOC of the Report@
http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=14945
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Appetite (Eating) Disorders Market size in terms of volume and value -2024 here
News-ID: 720779 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Appetite
Packaged Rice Market: Meeting the Appetite for Quick Meals
The packaged rice market has grown from being a basic staple industry into a dynamic, competitive segment driven by shifting consumer preferences, supply‐chain efficiencies, and innovations in branding. As rice continues to be one of the most widely consumed grains in the world, the way it is cultivated, processed, packaged, and marketed has experienced notable transformation. Today's landscape features an intersection of food security concerns, convenience‐driven consumption patterns, health consciousness,…
Appetite Stimulant Market Emerging Trends and Growth Prospects 2034
Appetite Stimulant market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Appetite Stimulant Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Appetite Suppressants Market Study Report and In-deep Analysis 2022
"Appetite Suppressants Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the worldwide Appetite…
Global Appetite Suppressants Market Insights, Forecast
Appetite suppressants are drugs that trick the body into believing it is not hungry. In the next few years, Appetite Suppressants industry will still be a relative highly energetic industry.The major drivers include the rising awareness among people, regarding health concerns, and the growing preference for supplements, which are convenient to maintain fitness. The global Appetite Suppressants market is valued at xx million US$ in 2018 and will reach xx…
Japan’s appetite for mergers and acquisitions abroad
The overall Mergers & Acquisitions (M&A) activity of Japanese firms continues to grow and overseas M&A deals are in the spotlight. In 2016, Japan’s outbound M&A activity exceeded USD100 billion, the second highest historic level and a 15% increase over 2015. Will Japan continue to tap into international markets in search of growth and sustainability?
Growing M&A activity
Significant cross-border M&A activity is a relatively recent phenomenon in Japan. Japanese M&A volume…
Appetite Disorders Market Global Industry Volume By Region 2016 - 2024
Although it is not a new disease, an appetite disorder can be related to modern lifestyle. In an attempt to reduce the weight and bring the body into shape people tend to decrease the normal food consumption. It is largely explained as a disturbed eating habit or disorders leading to significant impairing of physical and psychological health of the patient. Eating disorder also occurs with variety of other psychiatric illnesses…
